CD36 and steatosis: Interestingly, the modulation of LXRα on CD36 has only been previously reported in hepatocytes and contributed to the hepatic lipid metabolism disorder and steatosis.[30] Therefore, this further implies our previous inference that Dock5 may also have a potential role in hepatic lipid metabolism.